Shares of Mersana Therapeutics Inc. (MRSN), which closed at an all-time high of $25.70 yesterday, have gained an impressive 340 percent year-to-date, thanks to positive developments related to its clinical programs.
from RTT - Biotech https://ift.tt/3kubRUP
via IFTTT
No comments:
Post a Comment